These results suggest that MCAM expression is closely related to tumor invasive aggressiveness and metastatic progression, and importantly, they underscore the potential of MCAM as a biomarker for advanced GC, with possible diagnostic utility. The gene discussed is MCAM; the disease is neoplasm.